Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression

BACKGROUND: The aim of this study is to seek an association between markers of metastatic potential, drug resistance-related protein and monocarboxylate transporters in prostate cancer (CaP). METHODS: We evaluated the expression of invasive markers (CD147, CD44v3-10), drug-resistance protein (MDR1)...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, J, Chen, H, Madigan, M C, Cozzi, P J, Beretov, J, Xiao, W, Delprado, W J, Russell, P J, Li, Y
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965856/
https://www.ncbi.nlm.nih.gov/pubmed/20736947
http://dx.doi.org/10.1038/sj.bjc.6605839

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965856/
https://www.ncbi.nlm.nih.gov/pubmed/20736947
http://dx.doi.org/10.1038/sj.bjc.6605839

Ejemplares similares